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An intense broad resonance at 2.14 ppm present in high field (400, 500 and 600 MHz) Hahn spin-echo ‘H-NMR spectra of rat blood plasma, but 
absent from those of human blood plasma is attributable to the presence of terminal 0-acetylsialate sugars in the molecularly mobile carbohydrate 
side-chains of ‘acute-phase’ glycoproteins (predominantly a,-acid glycoprotein). The presence of such alternative acetylsugars in the carbohydrate 
side-chains of rat plasma glycoproteins are of much physiological and experimental significance in view of the regular use of these animals in model 
systems of human inflammatory conditions. 
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1. INTRODUCTION 
High resolution proton (‘H) nuclear magnetic reso- 
nance (NMR) spectroscopy is a well established and 
powerful tool which enables the rapid simultaneous 
study of complex mixtures of endogenous or, where 
appropriate, exogenous components present in biologi- 
cal matrices [141. The technique is largely non-invasive 
since it has little or no requirement for sample pre- 
treatment. Indeed, much useful biochemical and clinical 
information can be obtained from ‘H-NMR investiga- 
tions of body fluids such as blood plasma, urine, knee- 
joint synovial fluid and saliva. The broad overlapping 
resonances arising from the large number of macromol- 
ecules present are routinely suppressed by spin-echo 
Fourier-transform (SEFT) methods, resulting in pro- 
files which contain many well-resolved resonances at- 
tributable to a wide variety of low-molecular-mass 
(non-protein-bound) metabolites and the mobile por- 
tions of macromolecules which are detectable at concen- 
trations > 5 x 10e5 mol * dme3. 
Our interest in the applications of high field biomedi- 
cal NMR spectroscopy to the rapid diagnosis and as- 
sessment of a range of inflammatory diseases in hu- 
mans, and the ability of animal model systems to mimic 
such clinical conditions, has led us to perform a com- 
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parative evaluation of the ‘H-NMR profiles of both 
healthy human and rat blood plasmas. Throughout the 
course of these investigations it became clear that 
whereas ingle-pulse and SEFT ‘H spectra of all human 
plasmas contained only two distinct glycoprotein reso- 
nances located at 2.04 and 2.08 ppm (attributable to the 
-NHCOCH3 groups of N-acetylsugars present at the 
5,5’- and 2,7- positions respectively in the branching 
carbohydrate side-chains [5-8]), corresponding spectra 
of all rat plasma samples examined contained an addi- 
tional intense broad signal centred further downfield at 
2.14 ppm. 
In this communication we present evidence for the 
assignment of this 2.14 ppm rat plasma signal to 
glycoprotein acetylneuraminate sugars other than N- 
acetylneuraminate (sialate). The presence of these alter- 
native acetylsugars in the branching carbohydrate side- 
chains of rat plasma ‘acute-phase’ glycoproteins is dis- 
cussed in terms of their biochemical, physiological and 
pathological significance. 
2. MATERIALS AND METHODS 
2.1. Proton NMR measurements 
Proton (‘H) NMR measurements on human and rat plasma samples 
were conducted on Bruker WH 400, Bruker AMX-600 (University of 
London Intercollegiate Research Services (ULIRS), Queen Mary and 
Westfield College facilities, University of London, UK) and JEOL 
JNM-GSX 500 (ULIRS, Biomedical NMR centre, Birkbeck College, 
University of London, UK) spectrometers operating in quadrature 
detection mode at operating frequencies of 400.13,600.13 and 500.16 
MHz respectively for ‘H. All spectra were recorded at a probe temper- 
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ature of 298 K. Typically, 0.60 ml of biofluid was placed in a S-mm 
diameter NMR tube, and 0.07 ml of *HZ0 was added to provide a field 
frequency lock. The broad protein resonances were suppressed by the 
Hahn spin-echo sequence (D[90°x-t-1800y-f-colfect]), which was re- 
peated 128-996 times with t = 68 ms for the Bruker spectrometers, and 
60 ms for the JEOL JNM-GSX 500 facility. The intense water signal 
was suppressed by presaturation with gated decoupling during the 
delay between pulses. Proton Hahn spin-echo spectra of solutions of 
gfycoproteins, bovine submaxillary mu&, N-acetyfneuraminate and 
A’-gfycofyfneuraminate in 2H,0 were similarly acquired using 43- 
16,707 repetitions of the above pulse sequence. 
Corresponding single-pulse (ID) spectra of rat plasma ultrafiltrates, 
and ‘H,O solutions of gfycoproteins and ~-acetyfsugars were also 
obtained. Typical pulsing conditions were: 1165,363 free induction 
decays (FIDs) using 16,384 data points, 3@40” pulses and a 3 s pulse 
repetition rate, the fatter to allow full spin-lattice (T,) relaxation of the 
protons in the samples investigated. 
Chemical shifts of resonances in spectra of biofluids, and gfycopro- 
tein, mucin and N-acetyfsugar solutions were referenced to external 
sodium 3-trimethyfsifyf[2,2,3,3-zH~]propionate (TSP; 6 = 0.00 ppm). 
For plasma samples, the methyl group resonances of afanine 
(6 = 1.487 ppm), lactate (6 = 1.330 ppm) or vafine (6 = 1.050 ppm) 
served as secondary internal references. 
The relative intensities of each gfycoprotein signal in 400 MHz ‘H 
Hahn spin-echo spectra of rat plasma and authentic rat and human 
a,-acid gfycoprotein and transferrin samples were determined by efec- 
tronic integration. 
2.2. Sample collection and prepararion 
Human and rat ‘acute-phase’ gfycoproteins (a,-acid gfycoprotein 
and apotransferrin), bovine submaxillary mucin (containing ca. 12% 
(w/w) bound siafates), N-acetyfneuraminic a id (from sheep submaxif- 
Iary glands), and N-gfycofyfneuraminic acid (from porcine submaxif- 
fary glands) were purchased from Sigma, UK. Each gfycoprotein was 
dissolved in deuterium oxide (2H20) containing 2.86 x foe2 mof . dm-” 
phosphate buffer, pH 7.00 (meter eading), for ‘H-NMR analysis. The 
pH of stock solutions of ~-a~tyfneuraminic and ~-~ycolyfneuram- 
inic acids was adjusted to 7.00 with 10 mof . dme3 NaOD prior to 
dilution with phosphate-buffered ‘HZ0 to yield 5.00 x fO_’ mof drn-j 
solutions. Bovine submaxillary mucin (20 mg) was added to 2.00 ml 
of *H*O, the sample rotamixed, centrifuged to remove insoluble mate- 
rial and the supernatant (pH 5.5, meter reading) utifised for ‘H-NMR 
analysis and experiments with the enzyme neuraminidase described 
below. 
Samples of whole blood were obtained from healthy male Wistar 
rats (n = 12) via cardiac puncture under anaesthesia (Sagataf) immedi- 
ately prior to sacrifice by CO, asphyxiation. These samples were then 
centrifuged (2,~O x g) at 4°C and the plasma (hepa~nized) removed 
and stored at -20°C for a maxims duration of 72 h. Prior to ‘H- 
NMR analysis, rat plasma samples were thawed at ambient empera- 
ture. Relevant control experiments established that none of the criteria 
investigated were influenced by storage in the above manner. Where 
required, ultrafiltrates of rat plasma samples were obtained using 
Amicon centrifree micropartition devices (< 10 kDa molecular weight 
cut-oft). 
Blood was also collected from 8 consenting healthy male human 
volunteers and placed in sterile plastic vials containing lithium hepa- 
rin. The blood was centrifuged (2,000 x g) at 4°C and the resulting 
plasma stored and thawed as described above prior to conducting 
NMR me~urements. 
Mild basic hydrolysis of the U-acetyf groups of rat plasma gfycopro- 
tein carbohydrate side-chain O-acetylsiafate residues was conducted 
by adjusting 0.20 ml afiquots of 5 different rat plasma samples to pH 
11.5 with 1.00 mof dm-’ NaOH and allowing them to equilibrate at 
37°C for a period of 18 h with corresponding untreated (control) 
samples. Each sample was then re-adjusted to pH 7.4 with 1.00 
mof dm-’ HCf and made up to a volume of 0.50 ml with ‘H,O prior 
to ‘H-NMR analysis. SEFT ‘H-NMR spectra were also acquired on 
the control rat plasma samples. 
Aliquots of six of the rat plasma samples obtained (0.40 ml) were 
each adjusted to pH 5.0 with 1.00 mol I dm-’ HCf and then treated 
with the enzyme neuraminidase (Clostridiwn perfringens; Sigma, UK, 
5.8 or 8.7 units per ml) for 4.5 h at 37°C. Subsequently, samples were 
removed and their pH value retained at 5.0 to conserve O-acetyfsifate 
sugars which do not appear to de-O-acetyfate in the pH range of 336 
[9]. All samples were then stored at -20°C for 65 h prior to conducting 
NMR experiments. SEFT ‘H-NMR spectra were acquired on neu- 
raminidase-treated samples. Corresponding 0.40 ml afiquots of the 
above rat plasma samples untreated with neuraminidase but subjected 
to the same pH modification and equilibrated at 37°C for the same 
time periods served as controls which also underwent ‘H-NMR anal- 
ysis. Further control ex~riments established that there were no differ- 
ences between the SEFT ‘H-NMR spectra of these control samples 
and those adjusted to pH 5.0 as above and stored at 4*C for periods 
of up to 72 h. Where sufficient volumes of sample were available, 
control and neuraminidase-treated rat plasmas were ultrafiltered as 
described above prior to storage at -20°C and single-pulse ‘H-NMR 
spectra of the resulting ultrafiltrates obtained. 
Solutions of bovine submaxillary mucin in ‘Hz0 prepared as de- 
scribed above were also treated with Clostridium perfringens neuram- 
inidase (7.4 units per ml). SEFT ‘H-NMR spectra of these solutions 
were acquired following their equilibration at ambient emperature for 
periods of 0, 2.95 and 6.67 h. 
With the exception of an acetate signal located at 1.92 ppm, SEfl 
‘H-NMR spectra of the above commercially available neuraminidase 
preparation did not contain any resonances in the chemical shift re- 
gion of interest (1.70-2.30 ppm). 
3. RESULTS 
Fig. 1 shows the 0.80-2.80 ppm regions of typical 400 
MHz SEFT ‘H-NMR spectra of healthy rat and human 
plasma samples. The broad protein enveIope arising 
from the large number of macromolecules present in 
these samples is suppressed and only resonances attrib- 
utable to molecularly mobile protons (i.e. those with 
long T2 values) are present. Spectra of healthy human 
plasma samples contain intense broad resonances lo- 
cated at 2.04 ppm (signal I: dv,,, = 7.8 Hz) and 2.08 ppm 
(signal II: d~,,~ = 11.6 Hz) which are attributable to the 
N-acetyl-CH, group protons of N-acetylsugars (N-ace- 
tylneuraminate and ~-a~tylglucosamine) present in the 
5,5’- and 2,7- positions, respectiveIy, of the molecularly 
mobile carbohydrate side-chains of ‘acute-phase’ 
glycoproteins (predominantly q-acid glycoprotein), as 
previously reported by Bell et al. [8]. Corresponding 
SEFT ‘H-NMR spectra of rat plasma, however, con- 
tained a further intense broad singlet resonance located 
downfield at 2.14 ppm (signal III: dv,,, = 8.3 Hz) in 
addition to the 2.04 and 2.08 ppm signals observed in 
human plasma. These distinctive broad resonances 
present in SEFT ‘H spectra of all rat plasma samples 
investigated (n = 12) are almost identical to those of an 
authentic, commercially-available sample of rat q-acid 
glycoprotein (Fig. 2a) which has a molecular mass of 44 
kDa. The line-widths of the 2.04, 2.08 and 2.14 ppm 
signals in spectra of rat q-acid glycoprotein were 6.4, 
3.8 and 6.6 Hz, respectively. As expected, the 2.14 ppm 
resonance was absent from corresponding spectra of 
human q-acid glycoprotein (Fig. 2b). 
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Fig. 1.400 MHz ‘H Hahn spin-echo (t = 68 ms) spectra of the 0.80- 
2.80 ppm regions of (a) normal rat and (b) normal human blood 
plasmas. Typical spectra are shown. Resonances I, II (rat and human 
plasma) and III (rat plasma only) arise from the -COCH, group 
protons of acetylsugars present in the branching carbohydrate side- 
chains of ‘acute-phase’ glycoproteins (predominantly q-acid 
glycoprotein). The line-widths (dv,,,) of the rat plasma glycoprotein 
signals I, II and III are 7.2, 10.0 and 8.3 Hz, respectively. Abbrevia- 
tions: A, acetate-CH,; Ala, alanine-CH,; Bu, 3-o-hydroxybutyrate- 
CH,; Cit, citrate-CH,; Gln, and Gin,, /I- and y-CH, groups of glutam- 
ine respectively; Ile, isoleucine-CH,; Lac, lactate-CH,; LDL-, HDL- 
FA-CH,, acyl chain terminal -CH, groups of low- and high-density- 
lipoprotein-associated fatty acids (predominantly cholesterol esters); 
Prop, propane-l ,2-diol-CH,; Pyr, pyruvate-CH,; TAG-CH, and 
-(-CH,-),, predominantly chylomicron- and very-low-density-lipo- 
protein (VLDL)-associated triacylglycerol acyl chain terminal-CH, 
and bulk -CH,- groups respectively; Thr, threonine-CH,; Val, valine- 
CH,. The propane-1,2-diol detectable in spectra of rat plasma is a 
component of the vehicle employed for administration of the Sagatal 
anaesthetic. 
All three of these rat plasma glycoprotein acetylsugar 
signals were absent from single-pulse ‘H spectra of rat 
plasma ultrafiltrate (obtained by passage through an 
ultrafiltration membrane with a molecular weight cut- 
off of < 10 kDa), confirming the macromolecular na- 
ture of the components giving rise to them. Treatment 
of a typical rat plasma sample with rat a,-acid glycopro- 
tein (final concentration 2.0 mg/ml) resulted in a clear 
increase in the intensity of each of the 2.04, 2.08 and 
2.14 ppm resonances (data not shown). 
The 400 MHz SEFT ‘H-NMR spectra of rat and 
human apotransferrin are also compared in Fig. 2. 
Clearly, the spectrum of rat apotransferrin contains 
three carbohydrate side-chain signals centred at 2.04, 
2.08 and 2.14 ppm (d~,,~ =4.4, 3.0 and 4.0 Hz respec- 
tively), the latter being absent from the SEFT ‘H spec- 
trum of the corresponding human sample. The relative 
intensities of the 2.04, 2.08 and 2.14 ppm rat apotrans- 
ferrin signals were 1.00, 0.41 and 0.38, whereas for the 
SEFT ‘H spectrum of rat ccl-acid glycoprotein, these 
values were 1.00, 0.43 and 0.72, respectively, dem- 
onstrating that the branching carbohydrate side-chains 
of rat al-acid glycoprotein have a higher content of the 
species giving rise to the 2.14 ppm signal than those of 
rat apotransferrin. The intensity ratios of the 2.04 and 
2.08 ppm signals were similar for both ‘acute-phase’ 
glycoproteins. 
Since the 2.14 ppm rat plasma ‘acute-phase’ 
glycoprotein signal is conceivably ascribable to the O- 
acetyl-CH, group protons of glycosidically-bound O- 
acetylated N-acetyl- and N-glycolyl-neuraminates, the 
SEFT ‘H-NMR spectrum of this biofluid was com- 
pared with that of bovine submaxillary mucin (Fig. 3) 
which is known to contain a mixture of carbohydrate 
side-chain bound N-acetylneuraminate (NeuSAc), N- 
glycolylneuraminate (NeuSGc), N-acetyl-9-mono-O- 
acetylneuraminate (Neu5,9Ac,), N-acetyl-7-mono-O- 
acetylneuraminate (Neu5,7Ac,), N-acetyl-7,9-di-O-ace- 
tylneuraminate (Neu5,7,9Ac,), N-acetyl-7,8-di-O-ace- 
tylneuraminate (Neu5,7,8Ac,), and N-glycolyl-9-mono- 
0-acetylneuraminate (Neu9AcSGc) with relatively 
large amounts of the Neu5,9Ac, species. As expected, 
the 1.7-2.3 ppm regions of SEFT ‘H spectra of the 
bovine mucin sample bears a striking resemblance to 
that of rat plasma, and contains an intense broad singlet 
resonance located at 2.14 ppm. Moreover, a further 
similarity between these spectra is the presence of a 
weaker, broad singlet at 1.96 ppm @vu2 = 5.3 Hz in rat 
plasma). The broad N-acetyl-CH, group signal centred 
at 2.04 ppm in the mucin spectrum exhibits a clear 
heterogeneity, indicating several different, magneti- 
cally-distinct N-acetyl-CH, group environments for gly- 
cosidically-bound sialates. 
These data suggest that the 2.14 ppm rat plasma 
glycoprotein carbohydrate side-chain signal is assigna- 
ble to 0-acetyl-CH, group protons present in a mixture 
of two or more of the above sialate 0-acetyl esters. 
Indeed, ‘H-NMR analysis of rat plasmas at higher op- 
erating frequencies (500 and 600 MHz) demonstrated 
that their 2.14 ppm signal contains at least two overlap- 
ping components (e.g. Fig. 3a). 
Previous reports have demonstrated that both ‘free’ 
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Fig. 2. Partial 400 MHz ‘H Hahn spin-echo NMR spectra of 2H20 solutions of (a) rat and (b) human q-acid glycoprotein. The concentrations 
of these proteins were 1.67 (rat) and 8.33 mg/ml (human). Corresponding spectra of ‘Hz0 solutions of rat apotransferrin (1.67 mg/ml) and human 
apotransferrin (40 mg/ml) are shown in (c) and (d), respectively. Abbreviations: as in Fig. 1, with S representing side-chain sugar ring proton 
resonances. Acetate, citrate and lactate detectable in spectra of rat apotransferrin are impurities present in the commercially-available preparation 
employed for these studies. 
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Fig. 3. 1.50-2.50 ppm regions of 500 MHz ‘H Hahn spin-echo (t = 60 ms) NMR spectra of (a) rat plasma and (b) bovine submaxillary mucin. 
Abbreviations: as in Fig. 1. 
and glycosidically-bound sialates are de-0-acetylated in 
basic solution [9], and further evidence for the assign- 
ment of the broad 2.14 ppm rat plasma signal to O- 
acetylsialate species was provided by subjecting the in- 
tact biofluid to basic hydrolysis (pH 11.5) at 37’C for 
a period of 18 h, and monitoring modifications in the 
glycoprotein carbohydrate side-chain resonances. Fig. 
4 shows typical partial 600 MHz SEFT ‘H-NMR spec- 
tra of a rat plasma sample acquired before and after 
hydrolysis in the above manner. These spectra clearly 
demonstrate the elimination of the 2.14 ppm glycopro- 
tein signal on treatment with base, an observation ac- 
companied by a clear increase in the intensity of the 
broader 2.08 ppm resonance which is partially attribut- 
able to the -NHCOCH, group protons of terminal 
NeuSAc. As expected, a corresponding marked increase 
in the intensity of the acetate-CH, group signal 
(6 = 1.92 ppm) was observed following hydrolysis, con- 
fining the liberation of this carboxylate anion from 
glycoprotein sugar U-acetyl groups. Modifications in 
the line-shape of the 2.04 ppm resonance were also no- 
table following hydrolysis. These results were reproduc- 
ible in all five samples investigated. 
Although glycosidically-bound sialate 0-acetyl-CH, 
groups are less susceptible to basic hydrolysis than the 
corresponding ‘free’ sugars [9], the complete disappear- 
ance of the 2.14 ppm signal observed indicates that the 
conditions employed here were adequate for their hy- 
drolysis in intact rat plasma samples. 
500 MHz SEFT ‘H-NMR spectra of a typical healthy 
rat plasma sample obtained prior and subsequent o 
treatment with the enzyme neuraminidase at pH 5.0 are 
shown in Fig. 5a and b, respectively. The latter spec- 
270 
trum contains a series of new resonances, e.g. intense 
sharp singlets located at 2.060, 2.068 and 2.126 ppm, 
and multiplets centred at 1.833 and 2.221 ppm. The 
2.060, 1.833 and 2.221 ppm signals are assignable to 
‘free’ NeuSAc (Fig. 5c), consistent with previous reports 
[S], and those at 2.068 and 2.126 ppm to the N- and 
O-acetyl-CH, group protons, respectively, of 
Neu5,9Ac, ~-anomer) by a consideration of their 
chemical shift values and relative intensities (approxi- 
mately 1: l), and reference to ‘H-NMR data available on 
a number of naturally-occurring, ‘free’ 0-acetylated sia- 
lates [lo]. The identity of the 2.060, 1.833 and 2.221 ppm 
resonances was confirmed by ‘spiking’ neuraminidase- 
treated rat plasmas with an authentic Neu5Ac standard. 
However, previously reported ‘H-NMR spectra of 
Neu5,9Acz have shown that the H-3 axial (H-3,) and 
equatorial (H-3,,,) position proton resonances of this 
species have very similar chemical shift values to those 
of NeuSAc [lo], and hence the 1.833 and 2.221 ppm 
multiplets probably contain contributions from both 
sugars. Indeed, we were unable to resolve the H-3,,, and 
H-3,W. proton resonances of NeuSAc and Neu5Gc in an 
equtmolar mixture of the two sugars under similar ex- 
perimental conditions at an operating frequency of 400 
MHz. A consideration of chemical shift values suggests 
that the O-acetyl-CH, group of Neu5,9Ac, is the major 
contributor to the broad rat plasma 2.14 ppm signal 
when this sialate O-acetyl ester is glycosidally-bound. 
Indeed, this broad resonance was substantially reduced 
in intensity subsequent to neuraminidase treatment. As 
expected, the intensity of the 2,7-position N-acetylsugar 
signal (6 = 2.08 ppm) was also markedly diminished 
following treatment with this enzyme, as was that of the 
Volume 322. number 3 FEBSLETTERS May 1993 
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Fig. 4. Partial 600 MHz ‘H Hahn spin-echo (t = 68 ms) spectra of rat plasma (a) before and (b) after mild basic hydrolysis (pH 11 S) at 37°C for 
18 h. Rat plasma samples were re-adjusted to pH 7.4 with 1.00 mol ’ dm--’ HCI prior to acquisition of spectra. Typical spectra are shown. 
Abbreviations: as in Fig. 1. 
broad I .95 ppm signal which is conceivably ascribable 
to a small quantity of Neu5,7Ac, present in the terminal 
position of rat plasma glycoprotein carbohydrate side- 
chains. 
Further singlet resonances of lower intensity located 
at 1.982,2.~8,2.099,2.105,2.130,2.133and2.155ppm 
generated by neuraminidase treatment of rat plasmas 
illustrate the diversity of terminal sialate sugars in the 
branching carbohydrate side-chains of glycoproteins 
present in this biofluid. Assignment of these additional 
signals is complicated by the experimental conditions 
employed here which deviate from those previously re- 
ported [lo] (giving rise to small modifications in chemi- 
cal shift values for some signals) and the occurrence of 
two anomeric forms for each sialate sugar. However, 
intensity considerations uggest hat the 2.048 ppm res- 
onance may be attributable to the -NHCOCH, group 
of the ol-anomer of Neu5,9Ac,. Furthermore, two of the 
additional signals may arise from the N- and O-acetyl- 
CH, groups of Neu5,7Ac,. No resonances attributable 
to the -NH-CO-C&OH group protons of ‘free’ N-gly- 
colylneuraminates (i.e. NeuSGc and Neu9Ac,SGc) were 
detectable in the 4.14.2 ppm chemical shift range of 
SEFT ‘H-NMR spectra of rat plasmas pre-equilibrated 
with neuraminidase, indicating that both NeuSGc and 
NeuS)Ac,SGc are absent from the terminal position of 
the carbohydrate side-chains of glycoproteins present in 
this biofluid. The above observations were completely 
reproducible in a total of six different rat plasma sam- 
ples investigated. 
500 MHz single-pulse ‘H-NMR spectra of ultrafil- 
trates derived from control and neuraminidase-treated 
rat plasmas (Fig. 5d and e) confirmed that all of the 
new, sharp resonances generated via the actions of this 
enzyme could be assigned to low-molecular-mass, ‘free’ 
sialate sugars. The intensities of each of the two 
Neu5,9Ac, acetyl group substituent signals expressed 
relative to that of N-acetyf-CH, group of NeuSAc in 
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Fig. 5. 1 SO-2.30 ppm regions of 500 MHz ‘H Hahn spin-echo NMR spectra of rat blood plasma (a) before and (b) after treatment with the enzyme 
neuraminidase at pH 5.0 and 37°C (section 2). (c) Partial 400 MHz SEFT ‘H NMR spectrum of a 5.00 x 10e3 mol . dm-’ solution of N- 
acetylneuraminate in 2Hz0; (d) and (e) 1.50-2.30 ppm regions of 500 MHz single-pulse ‘H-NMR spectra of ultrafiltrates obtained from control 
and neuraminidase-treated ratplasma samples respectively. Typical spectra are shown. The 1 S&2.30 ppm regions of 500 MHz SEFT ‘H-NMR 
spectra of a solution of bovine submaxillary mucin in 2H,0 (pH 5.5) before and at 2.95 and 6.67 h after incubation with neuraminidase at ambient 
temperature (section 2) are shown in (0, (g) and (h) respectively. Abbreviations: as in Fig. 1, with NeuSAc-N-acetyl-CH,, H-3,. and H-3,. 
representing N-acetylneuraminate N-acetyl-CH,, H-3 axial and H-3 equatorial proton resonances, respectively, and Neu5,9Ac,-N-acetyl-CH,, 
0-acetyl-CH,, H-3.. and H-3,. representing N-acetyl-9-mono-O-acetylneuraminate N-acetyl-CH,, 0-acetyl-CH,, H-3 axial and H-3 equatorial 
proton resonances, respectively. Further new resonances for ‘free’ sialate sugars appearing subsequent to enzyme treatment are indicated by the 
arrows in (b), (e), (g) and (h). 
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ultrafiltrates of neuraminidase-treated rat plasma sam- 
ples was ca. 1.5:l .O. Additional weak resonances at 
2.110 (singlet) and 2.019 ppm (apparent triplet) were 
also present in spectra of ultrafiltrates obtained from 
neuraminidase-treated rat plasmas. Treatment of these 
0-acetylsilate-containing ultrafiltrates with NaOH 
(final pH 11.5) for 3.00 h at ambient temperature gave 
rise to the complete removal of all singlet resonances 
assignable to sialate 0-acetyl-CH, groups with a corre- 
sponding marked elevation in the intensities of those 
attributable to NeuSAc and acetate (data not shown), 
observations consistent with the lability of these NMR- 
sensitive reporter groups towards base. 
Typical SEFT ‘H-NMR spectra of a solution of bo- 
vine submaxillary mucin in ‘H20 obtained before and 
at two different time intervals after treatment with neu- 
raminidase at ambient temperature are shown in Fig. 
5f-h. Clearly, the cleavage of terminal sialates from the 
branching carbohydrate side-chains of this glycoprotein 
by neuraminidase gives rise to a range of new, sharp 
signals in a time-dependent manner, i.e. singlets at 
1.955, 1.984,2.045,2.060,2.069,2.104,2.125,2.130 and
2.156 ppm, and multiplets at 1.840 and 2.232 ppm. The 
2.060 ppm singlet resonance is attributable to the - 
NHCOCH, group protons of NeuSAc, and those at 
2.069 and 2.125 ppm to the N- and 0-acetyl-CH, 
groups, respectively, of Neu5,9Ac,. Although the multi- 
plets centred at 1.840 and 2.232 ppm are partially as- 
cribable to the H-3,,, and H-3,,. protons, respectively, 
of NeuSAc, these signals are also likely to contain major 
contributions from Neu5,9Ac,, NeuSGc and 
Neu9Ac,SGc in view of the availability of relatively high 
levels of these sialates in bovine submaxillary mucin 
[lo]. Sharp singlets located at 4.14 and 4.16 ppm were 
also detectable in SEFT ‘H-NMR spectra of neuram- 
inidase-treated mucin samples (data not shown), consis- 
tent with the enzymic liberation of N-glycolylneurami- 
nates such as NeuSGc and Neu9Ac,SGc from the termi- 
nal position of this glycoprotein’s carbohydrate side- 
chains. Certain of the additional singlet resonances in 
the spectra shown in Fig. 5g and h are conceivably 
attributable to the N- and 0-acetyl-CH, groups of the 
/3-anomer of Neu5,7Ac, (1.984 and 2.156 ppm) and the 
N-acetyl-CH, group of the a-anomer of Neu5,9Ac, 
(2.045 ppm), and the remaining signals may arise from 
the N- and 0-acetyl-CH, group protons of 
Neu5,7,9Ac,, Neu5,8,9Ac, and NeuSGc,9Ac in view of 
the prevalence of these sialates in bovine submaxillary 
mucin. Interestingly, a sharp doublet resonance of very 
weak intensity at 1.34 ppm was also generated in the 
spectrum on neuraminidase treatment (data not 
shown). This signal may be attributable to the O-lactyl- 
CH, group of sialate 0-lactyl esters, indicating the re- 
lease of terminal N-acetyl- or N-glycolyl-9-O-lactylneu- 
raminates. 
With the exception of the ‘free’ N-glycolyl- and O- 
lactyl-substituted neuraminates generated, the above re- 
sults are similar to those obtained on neuraminidase 
treatment of rat plasmas and demonstrate the time- 
dependence of the enzymic release of different sialate 
species from the terminal position of mucin’s carbohy- 
drate side-chains. 
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4. DISCUSSION 
The broad 2.14 ppm ‘acute-phase’ glycoprotein reso- 
nance present in SEFT ‘H-NMR spectra of rat plasma, 
but absent from those of all human plasma samples 
examined demonstrates ome degree of biological spec- 
ificity in terms of the chemical nature of the branching 
carbohydrate side-chain acetylsugars responsible for it. 
Indeed, in 1970 Schoop [l I] reported that whereas 
human ‘acute-phase’ glycoproteins contain only 
NeuSAc, serum glycoproteins of other mammals pos- 
sess 0-acetylated neuraminate derivatives (N-glycolyl, 
0-acetyl, N-,O-diacetyl and triacetyl-neuraminates) in
addition to NeuSAc. Previous high resolution ‘H NMR 
studies of blood plasma obtained from a variety of ver- 
tebrates (excluding rats) have provided evidence for 
some ‘between species’ heterogeneity in the chemical 
shift values and intensities of glycoprotein sugar acetyl- 
CH, group resonances [12], and hence the additional 
2.14 ppm signal detectable in SEFT ‘HNMR spectra of 
rat plasma, ascribable to 0-acetyl-CH, groups present 
in sialate 0-acetyl esters, is not unexpected. The data 
presented in this study clearly demonstrate that a,-acid 
glycoprotein, and, to a lesser extent, transferrin, con- 
tribute to each of the three glycoprotein signals ob- 
served in SEFT ‘H spectra of rat plasma, but haptog- 
lobin and ol,-antitrypsin may also augment the line- 
shape and intensity of these resonances. In correspond- 
ing spectra of human plasma, the 2.04 and 2.08 ppm 
glycoprotein N-acetylsugar resonances are predomi- 
nantly attributable to a,-acid glycoprotein (25.0% (w/w) 
Neu5Ac and N-acetylglucosamine [ 131) with haptog- 
lobin, transferrin and a,-antitrypsin (containing 10.0, 
3.6 and 3.8% (w/w) N-acetylsugars respectively [13]) 
contributing only to a relatively minor extent [8]. 
Assignment of the broad rat plasma 2.14 ppm reso- 
nance to 0-acetylsialate sugars (predominantly 
Neu5,9Ac,) present in the terminal position of ‘acute- 
phase’ glycoprotein carbohydrate side-chains is based 
on (i) comparisons of the 1.7-2.3 ppm regions of SEFT 
‘H spectra of this biofluid with that of bovine submax- 
illary mucin, a rich source of 0-acetylsialates (Fig. 3); 
(ii) the susceptibility of sialate 0-acetyl groups to mild 
basic hydrolysis (Fig. 4); and (iii) the identification of 
selected 0-acetylsialate species in spectra of neuram- 
inidase-treated rat plasmas and ultrafiltrates derived 
therefrom (Fig. 5). 
Examination of single-pulse ‘H spectra of ultrafil- 
trates obtained from neuraminidase-treated rat plasmas 
afforded an estimate of the relative quantities of 
Neu5Ac and Neu5,9Ac, liberated from glycoproteins 
present in this biofluid. Approximately 50% more 
Neu5,9Ac, than Neu5Ac was present in these samples, 
a value that should be considered as a lower limit in 
view of the increased resistance of glycosidically-bound 
0-acetylsialates to neuraminidase cleavage [9]. 
It should also be noted that some of the Neu5,9Ac, 
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detectable in spectra of neuraminidase-treated rat plas- 
mas may result from the migration of an 0-acetyl group 
from the 7-position in Neu5,7Ac, to the primary hy- 
droxyl group at the 9-position where it has enhanced 
stability [9,10]. However, Kamerling et al. [lo] have 
reported that incubation of Neu5,7Ac, at pH 5.0 and 
37°C does not give rise to significant 0-acetyl group 
migration within 24 h. 
Interestingly, the fraction of the broad 2.14 ppm sig- 
nal remaining in SEFT *H spectra of rat plasma subse- 
quent neuraminidase treatment may represent glycosid- 
ically-bound sialate species containing a 4-0-acetyl 
functional group, since 4-0-acetylation of sialate blocks 
the cleavage of these terminal sugars from sialocarbohy- 
drate chains by commercially available preparations of 
this enzyme [20,21]. 
Specific functions associated with the presence of gly- 
cosidically-bound 0-acetylsialates in biological systems 
include a diminished rate of cleavage from sialocarbo- 
hydrate chains by neuraminidase [37], an involvement 
in environmental adaption [38] and the binding of influ- 
enza C viruses [39], and an ability to influence alternate 
pathway complement activation [40] and bacterial anti- 
genicity [41]. Hence, such differences in the physiochem- 
ical properties of the glycoprotein carbohydrate side- 
chains between rat and human blood plasmas are likely 
to have important biochemical, physiological and pa- 
thological ramifications. 
Although previous suggestions for the functional 
status of glycoprotein carbohydrate side-chains include 
their non-specific actions as lubricants and stabilisers 
which confer negative charge [14], such moieties now 
have a well established role in molecular recognition 
processes [ 15,163. Indeed, recent evidence suggests that 
the carbohydrate side-chains of glycoproteins function 
as ‘address labels’ which direct compartmentalisation 
either intra- or extracellularly [14,17], and have regula- 
tory roles which involve their interactions with 
hormone receptors and lectin-like species located on cell 
membranes. Also of particular relevance to this area of 
investigation are the observations that: (i) a property of 
the carbohydrate moiety of a,-acid glycoprotein exerts 
a regulatory function towards various immune re- 
sponses [18]; and (ii) modifications in glycoprotein ter- 
minal sugar residues during synthesis or subsequent to 
partial degradation give rise to their intercompartmen- 
tal movement such as that involved in the endocytosis 
of material following macrophage membrane binding 
[17,19]. 
These data are also of much interest in the context of 
analytical biochemistry in view of reports that many 
conventional methods for the analysis of glycoconju- 
gates give rise to the destruction of sialate 0-acetyl sub- 
stituents [9], and 0-acetylation of sialate interferes with 
the commonly employed periodate-thiobarbituric acid 
assay system for determining trace levels of free N- 
acetyl- and N-glycolylneuraminates [21,22]. The facile, 
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non-destructive analysis of glycoprotein carbohydrate 
side-chains in biofluids by high field ‘H-NMR spectros- 
copy both prior and subsequent to neuraminidase treat- 
ment serves to offer much useful information regarding 
the precise molecular nature and levels of sialate sugars 
present. 
The concentrations of human plasma ‘acute-phase’ 
glycoproteins are of much clinical interest since they are 
known to be markedly elevated in a range of abnormal 
clinical conditions, e.g. inflammatory joint diseases, 
cancer, certain liver diseases, and also during surgical 
trauma [23-271. Indeed, inflammation arising from any 
form of tissue injury induces an increase in the levels of 
these ‘acute-phase’ proteins which are predominantly 
synthesized in liver parenchymal cells [28] in response 
to cytokines such as interleukins-1 and -6. Since cytok- 
ines released from cells at the inflammation site differ- 
entially induce this response [29], the nature and chron- 
icity of inflammation may be influenced by the molecu- 
lar structure, functional status and plasma levels of 
the glycoproteins generated. Hence, the precise chemi- 
cal nature of the branching carbohydrate side-chains 
of these proteins is likely to play an important role 
in the progression of inflammatory diseases such as 
synovitis, and Sharif et al. [30] have recently suggested 
that extracellular glycoproteins and glycosaminogly- 
cans bearing terminal N-acetylglucosamine residues 
may act as inflammatory stimuli in rheumatoid arthri- 
tis. 
The presence of terminal O-acetylsialate sugars in the 
molecularly mobile carbohydrate side-chains of rat 
‘acute-phase’ glycoproteins is of much significance in 
view of the regular use of these animals in models of 
human inflammatory conditions. Previous investiga- 
tions involving the measurement of ‘acute-phase’ reac- 
tants in animals are generally limited to models of 
chronic inflammation [31]. However, in these experi- 
mental models, modifications in the serum levels of 
‘acute phase’ proteins correlate well with disease activ- 
ity, its progression and effective therapeutic interven- 
tion [32]. 
In rats, both cl,-acid glycoprotein and cc,-macroglob- 
ulin are sensitive ‘acute-phase’ reactants that have been 
employed to quantitate the ‘acute-phase’ response [33]. 
Since the molecularly-mobile carbohydrate moiety of 
a,-acid glycoprotein is predominantly responsible for 
the three NMR-detectable glycoprotein signals present 
in SEFT ‘H spectra of rat plasma, further high field 
‘H-NMR studies are likely to be of much use in deter- 
mining the biofluid concentrations of this glycoprotein 
in experimental models of inflammation employing 
these animals. Moreover, high field ‘H-NMR analysis 
of rat plasma samples both prior and subsequent o 
neuraminidase treatment as described here permits an 
evaluation of any time-dependent modifications in the 
relative levels of particular glycoprotein sialate sugars 
(e.g. NeuSAc and Neu5,9Ac,) during progression of the 
disease process, and may yield much useful diagnostic 
information. 
The results obtained here are also of much interest in 
view of the powerful abilities of one or more heat-resis- 
tant macromolecular components of rat serum (A.R. 
Moore, personal communication) and air pouch inflam- 
matory exudate [34] to protect cartilage against degra- 
dation (monitored by glycosaminoglycan release). In- 
deed, the capacity of rat air pouch inflammatory exu- 
date to exert such activity has been suggested to arise 
from the biochemical actions of ‘acute-phase’ proteins 
[34]. Intriguingly, in early investigations pertinent to 
this research area Highberger et al. [35] and Franzblau 
et al. [36] found that a,-acid glycoprotein exerts an in- 
fluence on the spacing of collagen fibres formed from 
soluble collagen. Moreover, the desialyzed forms of this 
protein do not exhibit this properly [36] indicating that 
its carbohydrate side-chain terminal sialate sugars are 
involved in the production of striated collagen. Hence, 
a comparative evaluation of the relative abilities of rat 
and human plasmas, and al-acid glycoproteins, to in- 
hibit cartilage deterioration is warranted. 
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